NCT04817540
- Conditions
- HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
- Locations
-
- Gangnam Severance Hospital Seoul, South Korea
Clinical trial condition
HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
Explore clinical trials studying HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study